Articles
MULTIDISCIPLINARY DEVELOPMENT OF PHYTOTHERAPEUTIC PRODUCTS FROM NATIVE CENTRAL AMERICAN PLANTS
Article number
720_14
Pages
149 – 156
Language
English
Abstract
Based on ethnopharmacological research and their industrial potential, 10 plants were chosen for development of pharmaceutical products and sustainable utilization of subregional biodiversity.
These were: Arrabaidaea chica (anti-inflammatory and dye), Eclipta alba (hepatoprotective), Lippia graveolens (antimicrobial), Passiflora edulis (sedative), Petiveria alliacea (anti-inflammatory), Phlebodium decumanum (immunomodulator), Phlebodium pseudoaureum (solar protector), Phyla dulcis (expectorant), Quassia amara (digestive and insecticide) and Smilax domingensis (antifungal and antipsoriatic). Between 2001 and 2004, the collaboration between an academic institution and a private sector from each of the five Central American countries permitted an integral evaluation of the chosen plants.
During this period, the following activities were completed: a regional market study of the selected plants; establishments of specific agrotechnological parameters (conservation, propagation, cultivation, post-harvest handling); phytopharmaceutical technology (extract characterization, selection of markers, formulation and production); six training and technology transfer seminars (three in agrotechnology and three in phytopharmaceutical technology); and the publication of two technical manuals, one on cultivation and post-harvest technologies for medicinal plants, and the other on characterization and analysis of herbal drugs and phytotherapeutic products.
Both manuals include specific monographs on the 10 selected species.
By the middle of 2006, the outcome of this project will be at least one product per country.
These were: Arrabaidaea chica (anti-inflammatory and dye), Eclipta alba (hepatoprotective), Lippia graveolens (antimicrobial), Passiflora edulis (sedative), Petiveria alliacea (anti-inflammatory), Phlebodium decumanum (immunomodulator), Phlebodium pseudoaureum (solar protector), Phyla dulcis (expectorant), Quassia amara (digestive and insecticide) and Smilax domingensis (antifungal and antipsoriatic). Between 2001 and 2004, the collaboration between an academic institution and a private sector from each of the five Central American countries permitted an integral evaluation of the chosen plants.
During this period, the following activities were completed: a regional market study of the selected plants; establishments of specific agrotechnological parameters (conservation, propagation, cultivation, post-harvest handling); phytopharmaceutical technology (extract characterization, selection of markers, formulation and production); six training and technology transfer seminars (three in agrotechnology and three in phytopharmaceutical technology); and the publication of two technical manuals, one on cultivation and post-harvest technologies for medicinal plants, and the other on characterization and analysis of herbal drugs and phytotherapeutic products.
Both manuals include specific monographs on the 10 selected species.
By the middle of 2006, the outcome of this project will be at least one product per country.
Authors
A. Caceres, M.P. Gupta, R.A. Ocampo, J. Mendoza, M.R. Herrera, P.N. Solis, S.M. Cruz, V. Martinez
Keywords
Arrabaidaea chica, Eclipta alba, Lippia graveolens, medicinal plants, Passiflora edulis, Petiveria alliacea, Phlebodium decumanum, Phlebodium pseudoaureum, Phyla dulcis, Quassia amara, Smilax domingensis
Online Articles (19)